Drug intelligence / Profile preview

Loftim

Development stage: Unknown
Lead developer: Oak-Faith Pharmaceutical Resources
Modality: Small Molecules
Administration: Oral

Overview

Loftim is a generic pharmaceutical product manufactured by Oak-Faith Pharmaceutical Resources in Nigeria. It is formulated as an oral suspension. While the specific active ingredient is not explicitly detailed in the manufacturer's primary product list, the company's portfolio consists of established generic medications such as metronidazole, paracetamol, and ibuprofen. Based on common pharmaceutical naming conventions in the region and the company's focus on essential OTC and generic medicines, Loftim is marketed as a commercially available therapeutic option, likely targeting common ailments. It is currently in the approved/marketing phase in Nigeria.

Brand names: Loftim
Other names: Loftim Suspension

Beyond the preview

Go deeper on Loftim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Loftim.

Explore the full profile